SE7415305L - - Google Patents
Info
- Publication number
- SE7415305L SE7415305L SE7415305A SE7415305A SE7415305L SE 7415305 L SE7415305 L SE 7415305L SE 7415305 A SE7415305 A SE 7415305A SE 7415305 A SE7415305 A SE 7415305A SE 7415305 L SE7415305 L SE 7415305L
- Authority
- SE
- Sweden
- Prior art keywords
- peptide
- polymer
- bound
- liquid phase
- synthesis
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 229920000642 polymer Polymers 0.000 abstract 3
- 239000007791 liquid phase Substances 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000010647 peptide synthesis reaction Methods 0.000 abstract 1
- 229920001515 polyalkylene glycol Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
- C07K1/062—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for alpha- or omega-carboxy functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/042—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers characterised by the nature of the carrier
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2360794A DE2360794C2 (de) | 1973-12-06 | 1973-12-06 | Verfahren zur Herstellung von Peptiden |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE7415305L true SE7415305L (fr) | 1975-06-09 |
Family
ID=5900062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7415305A SE7415305L (fr) | 1973-12-06 | 1974-12-06 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US3960830A (fr) |
| JP (1) | JPS5088003A (fr) |
| BE (1) | BE823064A (fr) |
| CH (1) | CH605679A5 (fr) |
| DE (1) | DE2360794C2 (fr) |
| DK (1) | DK633374A (fr) |
| FR (1) | FR2253736B1 (fr) |
| GB (1) | GB1464938A (fr) |
| IE (1) | IE40281B1 (fr) |
| LU (1) | LU71415A1 (fr) |
| NL (1) | NL7415602A (fr) |
| SE (1) | SE7415305L (fr) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3997516A (en) * | 1974-07-04 | 1976-12-14 | Takeda Chemical Industries, Ltd. | Method for protecting guanidino group and restoring the same |
| DE2930542A1 (de) * | 1979-07-27 | 1981-02-12 | Hoechst Ag | Neue insulinderivate und verfahren zu ihrer herstellung |
| US4585757A (en) * | 1984-07-27 | 1986-04-29 | Texas Tech University Health Sciences Center | Hypotensive active peptides |
| US5206344A (en) * | 1985-06-26 | 1993-04-27 | Cetus Oncology Corporation | Interleukin-2 muteins and polymer conjugation thereof |
| US4766106A (en) * | 1985-06-26 | 1988-08-23 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
| US4847325A (en) * | 1988-01-20 | 1989-07-11 | Cetus Corporation | Conjugation of polymer to colony stimulating factor-1 |
| US4908404A (en) * | 1988-08-22 | 1990-03-13 | Biopolymers, Inc. | Synthetic amino acid-and/or peptide-containing graft copolymers |
| US5510418A (en) * | 1988-11-21 | 1996-04-23 | Collagen Corporation | Glycosaminoglycan-synthetic polymer conjugates |
| US5565519A (en) * | 1988-11-21 | 1996-10-15 | Collagen Corporation | Clear, chemically modified collagen-synthetic polymer conjugates for ophthalmic applications |
| US5306500A (en) * | 1988-11-21 | 1994-04-26 | Collagen Corporation | Method of augmenting tissue with collagen-polymer conjugates |
| US5162430A (en) * | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
| US5166322A (en) * | 1989-04-21 | 1992-11-24 | Genetics Institute | Cysteine added variants of interleukin-3 and chemical modifications thereof |
| JPH0520266U (ja) * | 1991-01-31 | 1993-03-12 | 松下電器産業株式会社 | 電気部品の接続装置 |
| EP0536671B1 (fr) * | 1991-10-07 | 1996-03-06 | Hoechst Aktiengesellschaft | Groupes de protection ester d'acides carboxyliques, procédé pour les synthétiser, leur couplage à un groupe fonctionnel et leur utilisation |
| US6458889B1 (en) | 1995-12-18 | 2002-10-01 | Cohesion Technologies, Inc. | Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
| ATE330644T1 (de) * | 1995-12-18 | 2006-07-15 | Angiotech Biomaterials Corp | Vernetzten polymerisatmassen und verfahren für ihre verwendung |
| US7883693B2 (en) | 1995-12-18 | 2011-02-08 | Angiodevice International Gmbh | Compositions and systems for forming crosslinked biomaterials and methods of preparation of use |
| US6833408B2 (en) * | 1995-12-18 | 2004-12-21 | Cohesion Technologies, Inc. | Methods for tissue repair using adhesive materials |
| US20030220258A1 (en) * | 2001-12-21 | 2003-11-27 | Robbert Benner | Treatment of ischemic events |
| US6552167B1 (en) * | 1998-08-28 | 2003-04-22 | Gryphon Therapeutics, Inc. | Polyamide chains of precise length |
| DK1656952T3 (da) * | 1998-10-16 | 2014-01-20 | Biogen Idec Inc | Polyalkylenglycolkonjugater af interferon beta-1A og anvendelser deraf |
| US7358330B2 (en) * | 2001-03-29 | 2008-04-15 | Biotempt B.V. | Immunoregulatory compositions |
| EP1300418A1 (fr) * | 2001-10-04 | 2003-04-09 | Erasmus Universiteit Rotterdam | Régulation génétique par des oligopeptides |
| US20080242837A1 (en) * | 2001-12-21 | 2008-10-02 | Khan Nisar A | Peptide compositions |
| US8129330B2 (en) * | 2002-09-30 | 2012-03-06 | Mountain View Pharmaceuticals, Inc. | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
| US20040219214A1 (en) * | 2002-12-30 | 2004-11-04 | Angiotech International Ag | Tissue reactive compounds and compositions and uses thereof |
| EP2181704B1 (fr) | 2002-12-30 | 2015-05-06 | Angiotech International Ag | Liberation de médicaments a partir d'une composition polymère à gélification rapide |
| US7517529B2 (en) * | 2003-04-08 | 2009-04-14 | Biotempt B.V. | Treatment of type I diabetes |
| US20090227505A1 (en) * | 2004-01-07 | 2009-09-10 | Biotempt B.V. | Methods and uses for protein breakdown products |
| WO2006078282A2 (fr) | 2004-04-28 | 2006-07-27 | Angiotech Biomaterials Corporation | Compositions et systemes permettant de former des biomateriaux reticules et procedes associes de preparation et d'utilisation |
| CA2579790A1 (fr) * | 2004-07-30 | 2006-02-09 | Mount Sinai School Of Medicine Of New York University | Inhibiteurs de npc1l1 et npc1l1 et procedes d'utilisation associes |
| EP1796602A4 (fr) | 2004-09-17 | 2016-10-19 | Angiotech Pharm Inc | Composes multifonctionels pour la formation de biomateriaux reticules et leurs procedes de preparation et d'utilisation |
| ES2615083T3 (es) * | 2005-09-20 | 2017-06-05 | Jitsubo Co., Ltd. | Vehículo de separación, método de separación de un compuesto, y método de síntesis del péptido utilizando el vehículo |
| EP1864692A1 (fr) * | 2006-06-07 | 2007-12-12 | Biotempt B.V. | Utilisation de peptides pour la protection contre les radiolésions |
| DK2120991T3 (da) * | 2007-02-12 | 2014-04-28 | Biotempt Bv | Behandling af traumatisk blødning med korte oligopeptider |
| EP2062909A1 (fr) * | 2007-11-21 | 2009-05-27 | SOLVAY (Société Anonyme) | Production de peptides et procédé de purification |
| US9051349B2 (en) | 2007-11-21 | 2015-06-09 | Alba Therapeutics Corporation | Larazotide acetate compositions |
| PT2376101E (pt) | 2008-12-29 | 2016-02-04 | Trevena Inc | Efectores da beta-arrestina e composições e métodos para a sua utilização |
| US9518086B2 (en) * | 2014-02-07 | 2016-12-13 | Trevena, Inc. | Crystalline and amorphous forms of a β-arrestin effector |
| JP2017518290A (ja) | 2014-05-19 | 2017-07-06 | トレベナ・インコーポレイテッドＴｒｅｖｅｎａ， Ｉｎｃ． | β−アレスチンエフェクターの合成 |
| WO2016011037A1 (fr) * | 2014-07-14 | 2016-01-21 | Peg Biosciences, Inc. | Promédicaments d'enképhaline polymères |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE337223B (fr) * | 1967-05-23 | 1971-08-02 | Pharmacia Ab | |
| US3502545A (en) * | 1968-09-27 | 1970-03-24 | Monsanto Co | Process for the separation of water-soluble polymeric materials from unbound protein or peptide using semiporous gel |
-
1973
- 1973-12-06 DE DE2360794A patent/DE2360794C2/de not_active Expired
-
1974
- 1974-11-29 NL NL7415602A patent/NL7415602A/xx unknown
- 1974-12-04 LU LU71415A patent/LU71415A1/xx unknown
- 1974-12-04 US US05/529,519 patent/US3960830A/en not_active Expired - Lifetime
- 1974-12-05 IE IE2512/74A patent/IE40281B1/en unknown
- 1974-12-05 CH CH1619674A patent/CH605679A5/xx not_active IP Right Cessation
- 1974-12-05 DK DK633374A patent/DK633374A/da unknown
- 1974-12-06 BE BE151258A patent/BE823064A/fr unknown
- 1974-12-06 GB GB5298774A patent/GB1464938A/en not_active Expired
- 1974-12-06 FR FR7440004A patent/FR2253736B1/fr not_active Expired
- 1974-12-06 JP JP49141098A patent/JPS5088003A/ja active Pending
- 1974-12-06 SE SE7415305A patent/SE7415305L/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DK633374A (fr) | 1975-07-21 |
| FR2253736A1 (fr) | 1975-07-04 |
| IE40281L (en) | 1975-06-06 |
| JPS5088003A (fr) | 1975-07-15 |
| US3960830A (en) | 1976-06-01 |
| FR2253736B1 (fr) | 1978-09-15 |
| LU71415A1 (fr) | 1976-11-11 |
| NL7415602A (nl) | 1975-06-10 |
| GB1464938A (en) | 1977-02-16 |
| CH605679A5 (fr) | 1978-10-13 |
| BE823064A (fr) | 1975-06-06 |
| IE40281B1 (en) | 1979-04-25 |
| DE2360794A1 (de) | 1975-06-26 |
| DE2360794C2 (de) | 1984-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE7415305L (fr) | ||
| IL44828A0 (en) | Isolation of coagulation factors from biological material | |
| CA1023287A (fr) | Procede de fixation d'une proteine sur un substrat | |
| CH537905A (fr) | Procédé de préparation de synthèse de peptides | |
| BE821121A (fr) | Procede de preparation d'un produit alimentaire proteique. | |
| ZA735376B (en) | Process for the separation of aliphatically unsaturated hydrocarbons from gaseous mixtures by permeation | |
| BE821211A (fr) | Procede de preparation d'un produit alimentaire proteique. | |
| CH551151A (fr) | Procede de preparation d'une fraction des proteines du soja. | |
| YU297374A (en) | Process for purifying water by means of distillation | |
| CS178816B2 (en) | Method for production of novel peptides | |
| CA1023291A (en) | Production of amino acids by protaminobacter | |
| FR2306005A1 (fr) | Procede pour separer des melanges de substances, de preference gazeux | |
| ZA745052B (en) | Process for the purification of gas streams | |
| IT985014B (it) | Procedimento per la separazio ne di idrocarburi alifatici insaturi in particolare etilene da miscele | |
| BE785933A (fr) | Procede de preparation de peptides contenant de la cystine | |
| IT1044732B (it) | Procedimento per la produzione di materiali proteici mediante fermentazione | |
| BE817731A (fr) | Produit d'adsorption pour les boissons | |
| CA1019324A (fr) | Procede de production de peptides | |
| RO70609A (fr) | Procede pour la preparation des peptides a action acth | |
| BE770447A (fr) | Production de proteines alimentaires d'origine unicellulaire par extraction en solvant | |
| BE820897A (nl) | Werkwijze voor de bereiding van synthese gas | |
| IL46238A0 (en) | Process for the purification of peptides | |
| BE815403A (fr) | Procede de preparation de peptides contenant de la cystine | |
| FR2347335A1 (fr) | Nouveaux peptides, resine-peptides intermediaires pour la synthese de ces peptides et procede de synthese de ces resine-peptides intermediaires | |
| CA964385A (en) | Process and apparatus for separating proteins from sea water by ozone |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 7415305-7 |